Skip to main content

Table 2 Normative ranges for the native ShMOLLI-T1 ranges for the most common myocardial tissue conditions encountered in clinical practice

From: Measurement of myocardial native T1 in cardiovascular diseases and norm in 1291 subjects

Native T1 [ms]

Reference myocardium

LGE+ or RWMA+ myocardium

Patients with normal CMR

938 ± 21

Cardiac Amyloidosis (AL)

1158 ± 75

Cardiac Amyloidosis (ATTR)

1002 ± 63

1061 ± 29

Anderson-Fabry Diseasec

863 ± 23

902 ± 17

Aortic Stenosis

952 ± 20

1019 ± 23a

Atrial Fibrillationc

945 ± 25

1010 ± 54

Chronic CAD

951 ± 33

1078 ± 94a

Dilated Cardiomyopathy

945 ± 27

1038 ± 38a

Hypertrophic Cardiomyopathy

932 ± 81

1041 ± 86a

Hypertension

944 ± 24

1022 ± 43a

Cardiac Iron-Overloadc

795 ± 58

Myocarditis (acute)

947 ± 39

1058 ± 74a

Myocarditis (previous)

941 ± 36

1026 ± 47a

Musculo-dystrophy

935 ± 23

1006 ± 10a

Obesity

936 ± 22

1031 ± 28a

Pheochromocytoma

939 ± 24

1006 ± 20a

Cardiac Sarcoidosis

934 ± 47

1030 ± 53a

Takotsubo Cardiomyopathyb

988 ± 41

1093 ± 64a

  1. All values are mean ± SD. RWMA regional wall motion abnormalities, LGE late gadolinium enhancement. All other abbreviations are as per Table 1
  2. ap < 0.001 compared to native T1 of reference myocardium
  3. bDisease entity in which affected myocardium is characterized by regional wall motion abnormalities (RWMA) only
  4. c- indicates material from extended analysis period included to address peer-review